Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients

M Prendecki, T Thomson, CL Clarke, P Martin… - The Lancet, 2021 - thelancet.com
Data are shown as median with IQR. Statistical analysis is by MannWhitney test (A) or
KruskallWallis test with Dunns posthoc correction (B).(A) Kidney transplant recipients who …

CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives

K Mortezaee, J Majidpoor - Frontiers in immunology, 2022 - frontiersin.org
Dysregulated innate and adaptive immunity is a sign of SARS-CoV-2-induced disease and
cancer. CD8+ T cells are important cells of the immune system. The cells belong to the …

Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated …

S Kanokudom, S Assawakosri, N Suntronwong… - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has become a severe healthcare
problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 …

[HTML][HTML] A promising vaccination strategy against COVID-19 on the horizon: heterologous immunization

J Myoung - Journal of microbiology and biotechnology, 2021 - ncbi.nlm.nih.gov
To overcome the ongoing COVID-19 pandemic, vaccination campaigns are the highest
priority of majority of countries. Limited supply and worldwide disproportionate availability …

New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination

MF Zavala-Miranda, SG González-Ibarra… - Kidney …, 2021 - kidney-international.org
To the editor: We read the report by Tuschen et al. of a 42-year-old woman with a previous
diagnosis of systemic lupus erythematosus (SLE) and class V lupus nephritis (LN) that …

Cellular immunity is critical for assessing COVID-19 vaccine effectiveness in immunocompromised individuals

E Paramithiotis, S Sugden, E Papp… - Frontiers in …, 2022 - frontiersin.org
COVID-19 vaccine clinical development was conducted with unprecedented speed.
Immunity measurements were concentrated on the antibody response which left significant …

Reduced T cell and antibody responses to inactivated coronavirus vaccine among individuals above 55 years old

GX Medeiros, GL Sasahara, JY Magawa… - Frontiers in …, 2022 - frontiersin.org
CoronaVac is an inactivated SARS-CoV-2 vaccine that has been rolled out in several low
and middle-income countries including Brazil, where it was the mainstay of the first wave of …

T cell responses to SARS-CoV-2 in humans and animals

SS Mattoo, J Myoung - Journal of Microbiology, 2022 - Springer
Abstract SARS-CoV-2, the causative agent of COVID-19, first emerged in 2019. Antibody
responses against SARS-CoV-2 have been given a lot of attention. However, the …

Comparison of humoral and cellular responses in kidney transplant recipients receiving BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines

M Prendecki, T Thomson, CL Clarke, P Martin… - MedRxiv, 2021 - medrxiv.org
Background Attenuated immune responses to mRNA SARS-CoV-2 vaccines have been
reported in solid organ transplant recipients. Most studies have assessed serological …

Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and …

A Body, E Ahern, L Lal, K Gillett, H Abdulla… - BMC infectious …, 2022 - Springer
Background Cancer is associated with excess morbidity and mortality from coronavirus
disease 2019 (COVID-19) following infection by the novel pandemic coronavirus SARS-CoV …